Close Menu

RNAi

The company is conducting in vivo testing with the La Jolla Institute for Allergy and Immunology.

The RNAi molecules have been licensed to Solstice Biologics, which is developing them for therapeutic applications.

The trial is set to run in Australia.

RXi Posts Flat Q3 Net Loss

Premium

NEW YORK (GenomeWeb) – RXi Pharmaceuticals this week reported its third-quarter financial results, posting a net loss essentially flat with last year as expenses held steady.

NEW YORK (GenomeWeb) – GeneSegues Therapeutics this week announced that it has received a $1 million contract from the National Cancer Institute to continue development of its gene-silencing cancer therapeutic GS-10.

NEW YORK (GenomeWeb) – The US Department of Agriculture has deregulated two RNAi-modified crop plants, potato and alfalfa, deeming that they do not pose a risk to other plants and therefore are not subject to certain regulatory requirements.

NEW YORK (GenomeWeb) – Arcturus Therapeutics this week released data showing that its lipid nanoparticle technology, dubbed Lunar, can deliver messenger RNA into non-human primates, triggering significant production of a therapeutic protein after a single dose.

NEW YORK (GenomeWeb) – Dicerna Pharmaceuticals last week reported its third-quarter financial results, posting higher losses amid increased spending on its drug-development programs.
Dicerna's net loss for the period rose to $11.2 million from $4.5 million the year before.

NEW YORK (GenomeWeb) – Alnylam Pharmaceuticals this week announced that it has expanded its pipeline to include programs in chronic hepatitis delta virus (HDV) and chronic liver infections.

NEW YORK (GenomeWeb) – Tekmira Pharmaceuticals may not be able to meet its year-end goal of providing US regulators with the data required to lift a hold on a Phase I trial of its investigational Ebola therapy TKM-Ebola, company officials disclosed last week.

Pages

The editorial board of the Pittsburgh Post-Gazette says other lawmakers should take Florida's approach and provide additional protections against genetic discrimination.

The Hill reports 17 states and the District of Columbia are suing over a new policy that would strip international students of their visas if they only attend classes online.

Centers for Disease Control and Prevention employees call on the agency to label racism a public health crisis and examine its own policies, NPR reports.

In PNAS this week: genetic evidence for Inca resettlement, analysis of spermatogonial stem cell transcriptomes, and more.